Skip to content
Trial Eligibility
Menu

Genicular Artery Embolization for Knee Osteoarthritis

NCT07537153

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Patients will be asked to take part in this research study because they have mild-to-moderate knee osteoarthritis (OA) and were referred clinically for a procedure called Genicular Artery Embolization (GAE). Osteoarthritis is the most common form of arthritis. It occurs when the protective cartilage that cushions the ends of the bones wears down over time. The symptoms of OA include pain or aching, stiffness, decreased range of motion, and swelling. The purpose of this study is to evaluate the safety and effectiveness of GAE for the treatment of knee pain attributed to OA.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Osteoarthritis
  • Knee Osteoarthritis

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
40 to 80 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Northwestern University
Last updated on ClinicalTrials.gov
July 14, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • Northwestern University · Chicago, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.